Ingrid A. Mayer

Molecular Biology · 2014–2020

A researcher in the Science corpus: 8 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Ingrid A. Mayer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Engelman
  2. B. Manning
  3. D. Guertin
  4. L. Salmena
  5. Lewis C. Cantley

Papers from Ingrid A. Mayer's perspective

Ordered by how strongly the researchers Ingrid A. Mayer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism (Nature reviews genetics)
  2. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. (Journal of Clinical Oncology)
  3. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways (Nature Medicine)
  4. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. (Journal of the American Medical Association (JAMA))
  5. Targeting PI3K signalling in cancer: opportunities, challenges and limitations (Nature Reviews. Cancer)
  6. An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer (Cancer Research)
  7. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence (Clinical Cancer Research)
  8. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)
  9. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. (Journal of Clinical Investigation)
  10. The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin*

Their papers